15th DSANJ Digital Bio Conference 2025
Call for presentation (proposal) project

15th D-Bio Digital'25 Call for presentation proposal

The Japan Agency for Medical Research and Development (AMED), the Japan Pharmaceutical Manufacturers Association (JPMA), the Osaka Chamber of Commerce and Industry (OCCI) and the Institute for New Drug Combinations (INN) are inviting presentations (proposals) at the 15th DSANJ Digital Bio Conference 2025 (hereafter referred to as “15th D-Bio Digital '25”) is an opportunity to partner with Japanese pharmaceutical companies.

At the 15th D-Bio Digital'25, you can use the web-based interview system (Zoom Meeting is planned) to meet with pharmaceutical companies (40 minutes per company on an individual basis) for partnering (e.g. joint research).

Due to the web interview system, 60 slots are scheduled for presentations. The presentations will be selected in the order of the research results with the highest number of requests for interviews from participating companies.

The application period is from Tuesday 5 November to Monday 4 December.

This is a valuable opportunity to collaborate with pharmaceutical companies (*Note 1). We look forward to your participation in the 15th D-Bio Digital'25 to accelerate the implementation of your research results in society.

(*Note 1) Around 40 companies are expected to participate.

Overview of the event

Date and time Wednesday 22, Thursday 23, Friday 24, Monday 27, Tuesday 28, and Wednesday 29 January 2025,
10:00 - 18:00
Organizers Japan Agency for Medical Research and Development (AMED), Japan Pharmaceutical Manufacturers Association(JPMA), Osaka Chamber of Commerce and Industry(OCCI).
Organizer and Programme promotion organization Bio New Combinations Research Institute
Administrative Office Inter Group Corporation
Co-organized by Osaka Prefecture and Kansai Pharmaceutical Association.
Supported by Osaka City
Venue You can use the web-based interview system (planned Zoom Meeting) to participate from a convenient location such as laboratories etc.
Participants About 60 Drug Seeds Proposer(s) (researchers from universities and other research institutions, start-ups, etc.) who hold research results related to drug discovery.
Around 40 pharmaceutical companies
Fee to participate Free of charge (no contingency fees or other costs will be incurred in the event of collaboration with participating pharmaceutical companies, such as joint research).

Registration outline

Notes on registration

1.Please do not include confidential information in your presentation (proposal) material (Form 3). Organizer(s) and the administrative Office will not handle any confidential information at the 15th D-Bio Digital'24.

2.Drug discovery projects that are related to Asia Partnership Conference of Pharmaceutical

Registration period Tuesday 5 November to Monday 4 December. 2025, noon
Eligible Drug Discovery projects

1.Drug discovery research project that intend to collaborate with Japanese pharmaceutical companies

2.Please limit one presentation (proposal) per researcher to one theme. If you wish to present (or propose) more than one theme, we kindly ask you to nominate a co-researcher or another person from the same research group.

Associations (APAC) led by JPMA.

Targeted Drug Discovery projects

Drug discovery seeds, drug discovery platform technologies, biomarkers, diagnostics and diagnostic technologies, digital therapeutics (e.g. apps), medical devices intended for use in combination with therapeutic agents, etc. (excluding medical devices used alone) that apply to any disease.
Metabolic diseases, cardiovascular diseases, bone and joint disease areas, infectious disease areas, respiratory disease areas, cancer and malignant neoplasms, central nervous system diseases, pain, ophthalmic diseases, immunology, inflammation, allergic diseases, skin diseases, gastrointestinal, urological diseases, gynaecological diseases and rare diseases.

How to registration for participation

Please access the following page to register your participation.

Participation documents

Click on the blue buttons to download the relevant documents.
*Please make sure to use the format of 15th D-Bio Digital’25 when editing material for participation.

Confirmation of participation (Form 2)

Presentation (proposal) material (Form 3)

Contact Information (Form 4)

Notes on the preparation of presentation (proposal) materials
Preparing your presentation (proposal) material in accordance with the guidelines will help attract the interest of pharmaceutical companies.
Due to the uploading and downloading of data, we ask that you resize the images to a size of around 20M (if the size is large, the Management Office may carry out the resizing process).

Even if you are not invited to the conference, your presentation (proposal) materials will be disclosed to the companies participating in the 15th D-Bio Digital'25.

How to registration for participation

Please follow the steps below to apply for participation.

Step 1.

Access the dedicated webpage for registration, fill in the required information and click on the registration button.

Step 2.

The Administrative Office will issue you with a D-Bio system ID and password, and you can log in to the system.

Step 3.

Upload the confirmation of participation (Form 2), your presentation (proposal) materials (Form 3) and business card information (Form 4) to the D-Bio system.

Invitation notification We will contact you via the D-Bio system in the last week of December to inform you of the number of companies we wish to interview.

Contact information

Organization 15th DSANJ Digital Bio Conference 2025 Administrative Office
(Inter Group Corporation)
Contact person Ms. Kambe, Ms. Yonezawa
Address 20-1, Toyosaki 3-chome, Kita-ku, Osaka 531-0072, Japan
E-mail info@dbio.jp
Tel Dedicated D-Bio Digital telephone number [050-5490-4115].
*If the above IP phones cannot be connected,Please call the Convention Department [06-6372-8455] of Intergroup Co., Ltd.
*Phone calls are answered between 10am and 5pm JST.
Above these hours, please contact us by email ❬ info@dbio.jp ❭.